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 Introduction 
 Brooke-Spiegler syndrome (BSS) is a rare autosomal-
dominant genetic disorder characterized by multiple ad-
nexal tumors, including cylindromas, spiradenomas, spi-
radenocylindromas and trichoepitheliomas (cribriform 
trichoblastomas). The tumors are mostly localized in the 
head and neck area and may undergo a malignant trans-
formation in 5–10% of cases  [1–4] . In addition, BSS pa-
tients may very rarely develop tumors of the major (pa-
rotid) and minor salivary glands, and exceptionally in the 
breast  [5–7] .
 Familial cylindromatosis and multiple familial tricho-
epitheliomas (MFT) are nowadays considered phenotyp-
ic variants of BSS: 1 patient may develop various types of 
tumors and/or different phenotypes may occur in the 
same family  [8–16] . All three conditions are caused by 
germline mutations in the same  CYLD gene  [17–20] .
 At the time of writing, a total of 95 distinct germline 
 CYLD mutations have been reported  [17, 21–28] . CYLD 
is a tumor suppressor gene located on chromosome 16q 
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 Abstract 
 Brooke-Spiegler syndrome is a rare autosomal-dominant ge-
netic disorder characterized by multiple adnexal tumors, in-
cluding cylindromas, spiradenomas, spiradenocylindromas 
and trichoepitheliomas. It is caused by germline  CYLD mu-
tations commonly leading to a premature stop codon. We 
here report on 3 novel  CYLD mutations in 3 unrelated BSS 
patients, including the classic phenotype, multiple familial 
trichoepitheliomas phenotype and malignant transforma-
tion. These included c.1821_1826+1delinsCT/L607Ffs * 9, 
c.2666A>T/p.D889V and c.2712delT/p.905Kfs * 8. By extend-
ing the spectrum of  CYLD mutations, better understanding 
of the molecular mechanisms of BSS can be gained, which 
might later assist in finding new treatment options. 
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 Fig. 1. Patient 1. Multiple skin-colored papules on the face favoring 
the nasolabial folds and eyelids (covered). 
Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e
a
Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e
 Fig. 2. a, b Patient 1. Cribriform trichoblastoma (trichoepithelio-
ma). Cribriform and solid basaloid cell aggregates focally resem-
bling follicular germ structures surrounded by specific follicular 
stroma resembling follicular papillae. 
?
a b c
 Fig. 3. Family pedigree of patient 1 ( a ), patient 2 ( b ) and patient 3 ( c ). 
b
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
5/
12
/2
01
6 
12
:0
2:
13
 P
M
 Tantcheva-Poór   et al.
 
Dermatology 2016;232:30–37
DOI: 10.1159/000437303
32
which has 20 exons and encodes a protein that negatively 
regulates the NF-κB and JNK pathways  [29] . Most germ-
line mutations reported to date are frameshift and non-
sense mutations commonly leading to a premature stop 
codon. We here report on 3 BSS patients (including 1 with 
a malignant phenotype) from 3 unrelated families with 
novel germline  CYLD mutations, thus extending the cat-
alogue of known germline  CYLD mutations.
 Patients and Methods 
 Patients 
 The main clinical data, histopathological and molecular find-
ings are summarized in  table 1 .
 Patient 1.  A 29-year-old woman presented with a few papules 
on her face, favoring the nasolabial folds and eyelids. She started 
developing them at the age of 13 years ( fig. 1 ). A shave biopsy of 
two papules revealed cribriform trichoblastoma (trichoepithelio-
ma) in each of the specimens ( fig. 2 ). The family pedigree showed 
an autosomal dominant mode of inheritance ( fig. 3 a).
 Patient 2. A 60-year-old man had multiple partly confluent 
tumors on his scalp ( fig. 4 ) which first appeared at the age of 40 
years. Some of the tumors had grown faster in the last 2 years, with 
the largest one (right temporal area) reaching the size of 5 × 3 × 
2.5 cm. Two out of four specimens showed stereotypical features 
of a cylindroma and a spiradenoma. The other two specimens re-
vealed malignant transformation of a preexisting spiradenocylin-
droma featuring nests and sheets of medium-sized pleomorphic 
basaloid cells with an infiltrative growth pattern and plentiful mi-
toses. The stroma was partly fibrous, partly myxoid with a retrac-
tion phenomenon. Lymphocytes were missing and the malignant 
moiety of the tumor was diffusely positive for p53 ( fig. 5 ,  6 ). The 
mother of the patient suffered from similar tumors on her scalp 
( fig. 6 b).
 Patient 3.  A 76-year-old woman presented with multiple skin 
tumors on her face and scalp, which had appeared at the age of
17 years. Two biopsies were taken, which revealed a spiradenocyl-
indroma and cribriform trichoblastoma (trichoepithelioma) next 
to an incipient spiradenocylindroma. Family members were af-
fected in an autosomal-dominant fashion ( fig. 3 c).
 Molecular Analysis 
 After obtaining the patients’ informed consent, analysis of 
germline  CYLD mutations was performed as described previous-
ly  [30] . Briefly, DNA was extracted from peripheral blood using 
a QIAsymphony DNA Mini Kit (Qiagen, Hilden, Germany) on 
an automated extraction system (QIAsymphonySP, Qiagen) ac-
cording to the manufacturer’s protocol. Coding sequences and 
 Fig. 4. Patient 2. Multiple variably sized red to bluish confluent 
nodules on the scalp. 
 Table 1.  Main clinicopathological data
Case Sex/age, 
years
Nationality/
ethnicity
Clinical features Available histology CYLD mutation
1 F/29 Swiss multiple paranasal papules 2 trichoepitheliomas c.2666A>T
2 M/60 Czech multiple confluent scalp tumors, 
the biggest one measuring 5 × 3 × 2.5 cm, 
with recent rapid growth
1 BCAC-HG evolving from 
spiradenocylindroma; 
1 spiradenoma; 1 cylindroma
c.2712delT
3 F/76 Slovak multiple tumors on the face and 
scalp
2 spiradenocylindromas;
1 trichoepithelioma
c.1821_1826+1delinsCT
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exon-intron junctions were amplified by HotStar Taq DNA 
Polymerase (QIAntigen, Hilden, Germany). PCR products were 
purified and sequenced bidirectionally, using the Big Dye Ter-
minator Sequencing Kit (Applied Biosystems, Carlsbad, Calif., 
USA) . In silico analysis of the impact of the mutation on protein 
structure and function was performed by PolyPhen-2 and 
PROVEAN.
 Results 
 Three novel  CYLD gene mutations were found and
the proteins were in silico predicted. These included 
c.1821_1826+1delinsCT/L607Ffs * 9, c.2666A>T/p.D889V 
and c.2712delT/p.905Kfs * 8 ( fig.  7 ). The prediction of 
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 Fig. 5. Patient 2. a Spiradenocylindroma composed of small nod-
ules arranged in jigsaw pattern (left) corresponding to cylindroma-
tous moiety in close proximity to large nodular aggregates repre-
senting spiradenomatous portion (right). b Close-up of the cylin-
dromatous part: note conspicuous droplets of hyaline basement 
membrane material. c Transitional area with cylindromatous jig-
saw pattern but numerous intratumoral lymphocytes, an essential 
component of a spiradenoma. d Area with sharp demarcation of 
spiradenomatous (upper right) and cylindromatous (lower left) 
components. 
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protein functionality by PolyPhen-2 and by PROVEAN 
revealed a malignant status of missense mutation (‘prob-
ably damaging’, score 0.999, and ‘deleterious’, respective-
ly).
 Discussion 
 In this study, we have reported three novel  CYLD mu-
tations in 3 unrelated BSS patients. Our patients have a 
variable phenotypic expression ranging from tiny pap-
ules on the face representing trichoepitheliomas in pa-
tient 1 (MFT phenotype) to multiple tumors on the scalp 
in patients 2 and 3. Additionally, in patient 2, malignant 
transformation of spiradenocylindroma has occurred, 
and the tumor was classified as a salivary gland-type bas-
al cell adenocarcinoma-like pattern, high-grade (BCAC-
HG). In a series of 24 malignant tumors evolving from 
preexisting benign spiradenoma, cylindroma and spi-
radenocylindroma, both sporadic and associated with 
BSS, this was the second most common type of a malig-
nant pattern after low-grade salivary gland-type BCAC 
 [31] . In the same study, a correlation between the histo-
logic pattern and clinical course was found in the sense 
that in patients with BCAC-HG, a more aggressive course 
is to be expected. The malignant portion was strikingly 
positive for p53, as is sometimes seen in these lesions 
 [32] .
 CYLD has no mutation hotspot, but the three novel 
germline mutations we identified are located in the usu-
ally mutated parts of the  CYLD gene, namely between ex-
ons 9 and 20 ( fig.  8 )  [27] . Two mutations represent a 
splice-site (patient 1) and a frameshift (patient 3) muta-
tion, resulting in a premature stop codon and, thus, sub-
stantially disturbing the protein structure. In patient 1, a 
missense mutation was found, meaning that a change in 
a single amino acid had occurred. Mutations that change 
an amino acid can differ in their impact on protein func-
a b
c
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 Fig. 6. Patient 2. a, b Malignant tumor evolving from a preexisting 
spiradenocylindroma. Remnants of spiradenomatous component 
can be recognized (a, upper portion) in close proximity to irregu-
lar infiltrative nodules (a, lower portion) composed of pleomor-
phic medium-sized to large basaloid cells with plentiful mitoses 
and necrotic cells (b). c Strong p53 expression in the malignant 
part of the tumor. 
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tion. In our case, the in silico analysis supports the claim 
of causality of this mutation.
 Using the current analysis (sequencing of coding se-
quences and exon-intron junctions), germline  CYLD mu-
tations are presently detected in about 76% of cases (the 
mutation frequency is about 85% for classic BSS and 44% 
for MFT)  [17, 33] . Mutations in introns leading to in-
tronic exonization and large deletions have been reported 
in some of those ‘negative’ cases  [30, 34] . So far, no geno-
type-phenotype correlation has been found  [11, 17, 35] . 
Bigger cohorts with accurate correlation of molecular, 
clinical and histomorphologic data may eventually help 
in developing prognostic criteria. By extending the spec-
trum of  CYLD mutations a better understanding of the 
molecular mechanisms of BSS can be gained. This might 
later assist in identifying new treatment options.
 Disclosure Statement 
 The authors have nothing to disclose to the editor regarding 
any direct or indirect financial implication that publication of this 
paper may have for them, their relatives or their institution. 
 
c.1821_1826+1delinsCT
c.2666A>T
c.2712delT
 Fig. 7. Sequences of the three novel mutations identified in our study (c.1821_1826+1delinsCT/L607Ffs*9
(case 3), c.2666A>T/p.D889V (case 1) and c.2712delT/p.905Kfs*8 (case 2).  
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161512 17 18 19 209 13 1410 111 2 3 4 5 6 7 8
AUG
1027dupA
1096del2
1112C>A
1135G>T
1139-148A>G
1178_1179delCA
1207C>T
1364_1365delAA
1392_1393dupT
1455T>A
1455T>G
1462delA
1518+2T>C
1569T>G
1628del2
1681_1682delTT
1682T>A
1684+1G>A
1758insGATA
1776delA
1787G>A
1821_1826delinsCT
IVS12+1G>A
1826+1G>T
1826+2T>G
1830_1831insA
1843delT
1859_1860delTG
1863insA
1893_1906del14
1935_1936insT
1950-2A>T
1950_1953delGATA
1961T>A
2012_2021del10
2041+1G>T
2042A>G
2065_2066delCT
2068_2069delTT
insC
2070delT
2081delT
2104_2105insA
2104delA
2108G>C
2109-2A>C
2116_2117
insATTAG
2119C>T
2128C>T
2138delA
2154insT
2155dupA
2164C>A
2170_2171insTC
2172delA
2214delT
2240A>G
2240_2241delAG
2253delG
2255delT
2259dupT
2272C>T
2288_2289delTT
2290del5
2299A>T
2305delA
2305_2306insC
2317G>A
2330_2331delTA
2335G>A err
2339T>G
2350+5G>A
2355_2358delCAGA
2409C>G
2449delT
2460delC
2467C>T
2469+1G>A
2686+60_*3340del5362
2687G>C
2711C>T
2712delT
2713C>T
2729dupC
2806C>T
2814_2817delGCTT
2822A>T
2546G>A
2552_2553insA
2569C>T
2602G>T
2613C>G
2641delG
2655G>A
2662_2664delTTT
2666A>T
561dupT
914-6398_1769del13642ins20
–34111_*297858del378779
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 Fig. 8. Presently identified germline mutations and their distribution in the  CYLD gene. Novel mutations are 
identified in red (modified from Grossmann et al.  [17] ). 
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